A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis

Neoadjuvant chemotherapy for gastric cancer: A meta-analysis of randomized, controlled trials

(2013) Yi Liao et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Japanese classification of gastric carcinoma: 3rd English edition

(2011)   Gastric Cancer

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

(2010) In Hae Park et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer

(2010) Hui-yan Luo et al.   CHEMOTHERAPY

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

(2010) Christoph Schuhmacher et al.   JOURNAL OF CLINICAL ONCOLOGY

Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer

(2008) Chaoying Liu et al.   ANTI-CANCER DRUGS

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

(2008) Mitsuru Sasako et al.   NEW ENGLAND JOURNAL OF MEDICINE

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

(2008) David Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE